Pearce DA - Search Results

1

Characterizing pathogenic processes in Batten disease: use of small eukaryotic model systems.

Phillips SN, Muzaffar N, Codlin S, Korey CA, Taschner PE, de Voer G, Mole SE, Pearce DA. Phillips SN, et al. Among authors: pearce da. Biochim Biophys Acta. 2006 Oct;1762(10):906-19. doi: 10.1016/j.bbadis.2006.08.010. Epub 2006 Sep 1. Biochim Biophys Acta. 2006. PMID: 17049819 Free article. Review.

2

BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase.

Pearce DA, Sherman F. Pearce DA, et al. Yeast. 1997 Jun 30;13(8):691-7. doi: 10.1002/(SICI)1097-0061(19970630)13:8<691::AID-YEA123>3.0.CO;2-D. Yeast. 1997. PMID: 9219333

3

A yeast model for the study of Batten disease.

Pearce DA, Sherman F. Pearce DA, et al. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6915-8. doi: 10.1073/pnas.95.12.6915. Proc Natl Acad Sci U S A. 1998. PMID: 9618513 Free PMC article.

4

Investigation of Batten disease with the yeast Saccharomyces cerevisiae.

Pearce DA, Sherman F. Pearce DA, et al. Mol Genet Metab. 1999 Apr;66(4):314-9. doi: 10.1006/mgme.1999.2820. Mol Genet Metab. 1999. PMID: 10191120 Free article.

5

Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?

Pearce DA. Pearce DA. J Neurosci Res. 2000 Jan 1;59(1):19-23. J Neurosci Res. 2000. PMID: 10658181 Review.

6

The yeast model for batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis.

Chattopadhyay S, Muzaffar NE, Sherman F, Pearce DA. Chattopadhyay S, et al. Among authors: pearce da. J Bacteriol. 2000 Nov;182(22):6418-23. doi: 10.1128/JB.182.22.6418-6423.2000. J Bacteriol. 2000. PMID: 11053386 Free PMC article.

7

Searching for interacting partners of CLN1, CLN2 and Btn1p with the two-hybrid system.

Cottone CD, Chattopadhyay S, Pearce DA. Cottone CD, et al. Among authors: pearce da. Eur J Paediatr Neurol. 2001;5 Suppl A:95-8. doi: 10.1053/ejpn.2000.0442. Eur J Paediatr Neurol. 2001. PMID: 11589016

8

An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA. Chattopadhyay S, et al. Among authors: pearce da. Hum Mol Genet. 2002 Jun 1;11(12):1421-31. doi: 10.1093/hmg/11.12.1421. Hum Mol Genet. 2002. PMID: 12023984

9

The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Weimer JM, Kriscenski-Perry E, Elshatory Y, Pearce DA. Weimer JM, et al. Among authors: pearce da. Neuromolecular Med. 2002;1(2):111-24. doi: 10.1385/NMM:1:2:111. Neuromolecular Med. 2002. PMID: 12025857 Review.

10

Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.

Kriscenski-Perry E, Applegate CD, Serour A, Mhyre TR, Leonardo CC, Pearce DA. Kriscenski-Perry E, et al. Among authors: pearce da. Epilepsia. 2002 Oct;43(10):1137-40. doi: 10.1046/j.1528-1157.2002.16002.x. Epilepsia. 2002. PMID: 12366726 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters